General Information of the Compound
| Compound ID |
CP0508543
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-(4-Phenoxy-phenyl)-1H-pyrazole
Show/Hide
|
||||||||||||||||||
| Synonyms |
111273-31-5
1H-Pyrazole, 3-(4-phenoxyphenyl)-
3-(4-Phenoxy-phenyl)-1H-pyrazole
3-(4-phenoxyphenyl)-1H-pyrazole
5-(4-phenoxyphenyl)-1H-pyrazole
AC1MD5RK
ACMC-20me6r
AKOS023552923
BDBM50141064
CHEMBL41864
CTK0G1854
DTXSID00384478
HMS1434K20
HMS2799J18
IDI1_012683
MCULE-9803599814
MLS000851363
Maybridge3_001296
MolPort-001-792-591
Oprea1_637414
SCHEMBL3364770
SGQSMRQYEPPNIA-UHFFFAOYSA-N
ZINC13559817
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H12N2O
|
||||||||||||||||||
| Molecular Weight |
236.274
|
||||||||||||||||||
| Canonical SMILES |
O(c1ccccc1)c1ccc(cc1)-c1cc[nH]n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H12N2O/c1-2-4-13(5-3-1)18-14-8-6-12(7-9-14)15-10-11-16-17-15/h1-11H,(H,16,17)
Show/Hide
|
||||||||||||||||||
| InChIKey |
SGQSMRQYEPPNIA-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound